tert-Butyl 3-(isopropylamino)azetidine-1-carboxylate, 97%, 1g

3-Phenylpyrrolidin-2-one, 95.0%, 5g

Methyl 5-bromo-1H-pyrazole-3-carboxylate, 95.0%, 10g

2-(Benzo[b]thiophen-2-yl)ethan-1-amine hydrochloride, 95%, 5g

2-(6-Methoxy-1,2,3,4-tetrahydronaphthalen-2-yl)acetic acid, 95.0%, 250mg

2-Nitrobenzene-1,4-diol, 95.0%, 1g

4-BROMOQUINOLIN-8-AMINE, 95.0%, 1g

Objetivo de contraste de fase Plan PLPH 10x/0,25

1-Acetyl-3-bromo-4-chloroindole, 97.0%, 5g

4-Methyl-2,3-dihydro-1H-inden-1-one, 95.0%, 25g

2-Fluoro-3-(trifluoromethyl)benzaldehyde, 97.0%, 5g

2,2-Bis (4-aminophenyl)hexafluoropropane, 95.0%, 10g

2-{[(butan-2-yl)amino]methyl}phenol, 95.0%, 1g